$2.00
-0.15-6.98%
At close: -
$2.11
0.115.50%
After Hours: 8:23 AM EDT
Comments
Loading...
Sunshine Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:SBFM | Benzinga
Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS
$-0.940
Quarterly Revenue
$8.44M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$32.96M
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SBFM | Sunshine Biopharma | -$40.00 | — | — | — | $7.54M | — | — | — | 05/19/2025 | Get Alert |
| SBFM | Sunshine Biopharma | -$120.00 | — | — | — | $7.68M | $12.50M | — | — | 04/08/2025 | Get Alert |
| SBFM | Sunshine Biopharma | -$50.72 | $0.00 | -$0.94 | -100.00% | $5.60M | $11.80M | $8.44M | -28.52% | 11/05/2024 | Get Alert |
| SBFM | Sunshine Biopharma | -$71.17 | -$7.40 | -$9.94 | -34.32% | $5.56M | $9.00M | $9.30M | 3.37% | 08/16/2024 | Get Alert |
| SBFM | Sunshine Biopharma | -$160.00 | -$160.00 | -$40.00 | 75.00% | $4.89M | $7.00M | $7.54M | 7.73% | 05/20/2024 | Get Alert |
| SBFM | Sunshine Biopharma | -$3.00K | -$60.00 | -$120.00 | -100.00% | $3.94M | $6.10M | $7.68M | 25.90% | 03/28/2024 | Get Alert |
| SBFM | Sunshine Biopharma | -$160.00 | -$120.00 | -$80.00 | 33.33% | $132.81K | $6.00M | $5.60M | -6.70% | 11/13/2023 | Get Alert |
| SBFM | Sunshine Biopharma | -$60.00 | — | -$40.00 | — | $150.31K | — | $5.56M | — | 08/10/2023 | Get Alert |
| SBFM | Sunshine Biopharma | -$460.00 | — | -$160.00 | — | $122.64K | — | $4.89M | — | 05/10/2023 | Get Alert |
| SBFM | Sunshine Biopharma | — | — | -$3.00K | — | — | — | $3.94M | — | 04/04/2023 | Get Alert |
| SBFM | Sunshine Biopharma | -$3.18K | — | -$160.00 | — | $50.38K | — | $132.81K | — | 11/07/2022 | Get Alert |
| SBFM | Sunshine Biopharma | -$2.42K | — | -$60.00 | — | $52.87K | — | $150.31K | — | 08/06/2022 | Get Alert |
| SBFM | Sunshine Biopharma | -$5.64K | — | -$460.00 | — | $40.06K | — | $122.64K | — | 05/06/2022 | Get Alert |
Sunshine Biopharma (SBFM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $-0.94 | $0 | -100.0 % |
| Q2 | 2024-08-16 | $-9.94 | $-7.40 | -34.3 % |
| Q1 | 2024-05-20 | $-40.00 | $-160.00 | 75.0 % |
| Q4 | 2024-03-28 | $-120.00 | $-60.00 | -100.0 % |
Sunshine Biopharma (SBFM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $8.44M | $11.80M | -28.5 % |
| Q2 | 2024-08-16 | $9.30M | $9.00M | 3.37 % |
| Q1 | 2024-05-20 | $7.54M | $7.00M | 7.73 % |
| Q4 | 2024-03-28 | $7.68M | $6.10M | 25.9 % |
FAQ
When is Sunshine Biopharma (NASDAQ:SBFM) reporting earnings?
Sunshine Biopharma (SBFM) is scheduled to report earnings on May 19, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
What were the latest earnings per share (EPS) for Sunshine Biopharma (NASDAQ:SBFM)?
The Actual EPS was $-0.94, which missed the estimate of $0.00.
What were Sunshine Biopharma’s (NASDAQ:SBFM) revenues?
The Actual Revenue was $8.4M, which missed the estimate of $11.8M.
Browse earnings estimates, EPS, and revenue on all stocks.